Publications by authors named "E Billaud"

Claim this Profile
R
Real-world effectiveness and safety of bulevirtide monotherapy for up to 96 weeks in patients with HDV-related cirrhosis.
Elisabetta Degasperi, Maria Paola Anolli, Mathias Jachs, Thomas Reiberger, Victor De Ledinghen, Eric Billaud

J Hepatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current evidence gaps to support systematic cytomegalovirus screening in pregnancy.
Agathe Billette de Villemeur, Bruno Hoen, Eric Billaud, Philippe Deruelle, Karine Goueslard

EClinicalMedicine· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with bulevirtide in HIV-infected patients with chronic hepatitis D: ANRS HD EP01 BuleDelta and compassionate cohort.
Victor de Lédinghen, Claire Fougerou-Leurent, Estelle Le Pabic, Stanislas Pol, Dulce Alfaiate, Eric Billaud

JHEP Rep· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective assessment of the frequency of and risk factors for bleeding events in patients treated with cefazolin.
Emmanuelle Gras, Yohann Tran, Benjamin Kably, Agnès Lillo-Lelouet, Thibaut Caruba, Eliane Billaud

Infection· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the heart valve tissue diffusion of amoxicillin in infective endocarditis: a pilot prospective observational non-comparative study.
Marie Dubert, Benjamin Kably, Audrey Derobertmasure, Isabelle Podglajen, Laura Munte, Eliane Billaud

J Antimicrob Chemother· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis